Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study (vol 4, e271, 2015)

被引：13
|
作者：
Greenberg, A. J.
Philip, S.
Paner, A.
Velinova, S.
Badros, A.
Catchatourian, R.
Ketterling, R.
Kyle, R. A.
Kumar, S.
Vachon, C. M.
Rajkumar, S. V.
机构：
来源：
BLOOD CANCER JOURNAL | 2015年 / 5卷
关键词：
D O I：
10.1038/bcj.2015.8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: Blood Cancer Journal (2015) 4, e271; doi:10.1038/bcj.2014.91; published online 2 January 2015 Since publication, the publishers have identified that this article was incorrectly placed in volume 4. The article belongs in volume 5. The publishers would like to apologise for any inconvenience caused.
引用
收藏
页码：e279 / e279
页数：1
相关论文
共 50 条
  • [21] A prospective multi-center trial of non-in-terventional and observational study of lenalidomide in Chinese patients with multiple myeloma
    王国苗
    China Medical Abstracts(Internal Medicine), 2017, 34 (03) : 184 - 185
  • [22] A phase 1, multi-center, dose escalation study of atiprimod in patients with refractory or relapsed multiple myeloma (MM).
    Wang, M
    Talpaz, M
    Jagannath, S
    Chanan-Khan, AA
    Alexanian, R
    Weber, DM
    Gavino, M
    Estrov, Z
    Harris, PJ
    Picker, D
    Schlossman, RL
    Tassone, P
    Anderson, KC
    Munshi, NC
    BLOOD, 2005, 106 (11) : 36A - 37A
  • [23] Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database
    Calip, Gregory S.
    Ascha, Mustafa S.
    Wang, Xiaoliang
    Pierre, Amy E.
    Maignan, Kathleen
    Wade, Niquelle B.
    Leng, Siyang
    Seymour, Erlene K.
    C-HChiu, Brian
    Sweiss, Karen
    Patel, Pritesh R.
    Neparidze, Natalia
    BLOOD, 2021, 138
  • [24] A multi-center phase I/II study of melphalan, prednisone, thalidomide and defibrotide in avanced multiple myeloma patients.
    Palumbo, Antonio
    Rus, Cecilia
    Rossi, Davide
    Pregno, Patrizia
    Ambrosini, Maria Teresa
    Avonto, Ilaria
    Gay, Francesca
    Cavallo, Federica
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    Boccadoro, Mario
    BLOOD, 2006, 108 (11) : 1016A - 1017A
  • [25] Autologous peripheral stem cell transplantation as a first line treatment for multiple myeloma: A Korean multi-center study.
    Bang, SM
    Lee, JH
    Suh, C
    Yoon, SS
    Seong, CM
    Cho, KS
    Kang, YG
    Park, S
    Ahn, MJ
    BLOOD, 2002, 100 (11) : 480B - 480B
  • [26] CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy (vol 271, pg 5368, 2024)
    Dell'Isola, Giovanni Battista
    Fattorusso, Antonella
    Pisani, Francesco
    Mastrangelo, Mario
    Cordelli, Duccio Maria
    Pavone, Piero
    Parisi, Pasquale
    Ferretti, Alessandro
    Operto, Francesca Felicia
    Elia, Maurizio
    Carotenuto, Marco
    Pruna, Dario
    Matricardi, Sara
    Spezia, Elisabetta
    Spalice, Alberto
    Scorrano, Giovanna
    Savasta, Salvatore
    Prontera, Paolo
    Di Cara, Giuseppe
    Fruttini, Daniela
    Salpietro, Vincenzo
    Striano, Pasquale
    Verrotti, Alberto
    JOURNAL OF NEUROLOGY, 2024, : 7648 - 7649
  • [27] A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multi-Center Study
    Hungria, Vania T. M.
    Bittencourt, Rosane
    Martinez, Gracia
    Santos, Juliana De Andrade
    de Almeida, Denise Ramos
    De Piratininga Figueiredo, Vera Lucia
    Cordeiro De Farias, Danielle Leao
    Zanella, Karla Richter
    Muniz, Larissa Barchi
    Carvalho, Pedro
    Senra, Juliana
    Abreu, Rodrigo Martins
    Mattos, Ederson Roberto
    BLOOD, 2022, 140 : 4352 - 4353
  • [28] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study
    Shragai, Tamir
    Magen, Hila
    Lavi, Noa
    Gatt, Moshe
    Trestman, Svetlana
    Zektser, Miri
    Ganzel, Chezi
    Jarchowsky, Osant
    Berger, Tamar
    Tadmor, Tamar
    Leiba, Merav
    Hertzog-Zarfaty, Katrin
    Horowitz, Netanel
    Shapira, Michael
    Varssano, David
    Berger, Yoav
    Frenkel, Shahar
    Krauthammer, Mark
    Avivi, Irit
    Luttwak, Efrat
    Cohen, Yael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S98 - S98
  • [29] Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study
    Jasielec, Jagoda
    Zonder, Jeff
    Derman, Benjamin A.
    Reece, Donna E.
    Cole, Craig E.
    Berdeja, Jesus G.
    Wolfe, Brittany
    Major, Sarah
    Tinari, Kathryn M.
    Stefka, Andrew
    Fazzi, Fabrizio
    Whelan, Megan
    Gleason, Christine
    McIver, Amanda
    Andreatos, Evangelia
    Libao, Bernadette M.
    Juergens, Daniel
    Griffith, Kent
    Jakubowiak, Andrzej
    BLOOD, 2020, 136
  • [30] Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
    Marlies Antlanger
    Tobias Dust
    Thomas Reiter
    Alexandra Böhm
    Wolfgang W. Lamm
    Max Gornicec
    Ella Willenbacher
    David Nachbaur
    Roman Weger
    Werner Rabitsch
    Susanne Rasoul-Rockenschaub
    Nina Worel
    Daniel Lechner
    Hildegard Greinix
    Felix Keil
    Heinz Gisslinger
    Hermine Agis
    Maria-Theresa Krauth
    BMC Cancer, 18
12345